An extensive study of potential inhibitors of extracellular vesicles release in triple-negative breast cancer.
Niamh McNameeMariadelva CatalanoAnindya MukhopadhyaLorraine O'DriscollPublished in: BMC cancer (2023)
Up to 98% inhibition of EVs' release was achieved. To prevent the transmission of undesirable phenotypic traits by EVs, their total inhibition may be necessary.